Drawing for GUNA

USPTO serial 79260426

GUNA

Reviewed by CopyMark Law Group

Reg. 5929539Status 739Registered
Filing date
Status date
Registration date
Dec 10, 2019
Examiner
MICHAUD-KING, JILLIAN L
Law office
TMO LAW OFFICE 122

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with GUNA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Molly Hunsinger

Molly Hunsinger LADAS & PARRY LLP224 S. Michigan Ave., Ste. 1600CHICAGO, IL 60604United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and homeopathic pharmaceutical preparations for skin care; pharmaceutical, [ veterinary, ] homeopathic pharmaceutical [ and homeopathic veterinary ] preparations for the treatment of itching due to skin injection or skin rashes and for the treatment of skin diseases and irritations; pharmaceutical and homeopathic pharmaceutical preparations for relieving stress and curing insomnia, for treating anxiety and mood swings, for improving concentration and memory; pharmaceutical, [ veterinary, ] homeopathic pharmaceutical and [ homeopathic veterinary ] preparations for the treatment of gastro-intestinal, circulatory, cardiovascular, urinary system, prostate, mouth and teeth diseases; pharmaceutical and homeopathic pharmaceutical preparations for the treatment of fatigue, muscle cramps and soreness; [ pharmaceutical, veterinary, ] homeopathic pharmaceutical and [ homeopathic veterinary ] preparations for the treatment of cough, headache, cold and flu, sore throat and tonsillitis, sinusitis, hypertension, hemorrhoids; pharmaceutical and homeopathic pharmaceutical preparations for the treatment of gynecological disorders of menstrual cycle, of menopause syndrome, of candidiasis [ , of herpes, of papilloma, and for the treatment of sexual disorders and andropause ] ; pharmaceutical, [ veterinary, ] homeopathic pharmaceutical and [ homeopathic veterinary ] preparations for the treatment of articular, muscular and nerve pain and diseases; food supplements for medical [ and veterinary ] purposes; insect repellents [ ; disinfectants ]ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 13, 2026INNPPARTIAL INVALIDATION PROCESSED BY THE IB
Jul 22, 2026INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jul 22, 2026INPCINVALIDATION PROCESSED
Jul 10, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 28, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 28, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 18, 2025NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Oct 28, 2025COC.CORRECTION UNDER SECTION 7 - PROCESSED
Oct 20, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 31, 2025ES7RTEAS SECTION 7 REQUEST RECEIVED
Apr 28, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Apr 28, 2025C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 28, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 19, 2024ES75TEAS SECTION 71 & 15 RECEIVED
Dec 10, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 10, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Mar 25, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB
Mar 25, 2020FIMPFINAL DISPOSITION PROCESSED
Mar 10, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 10, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 5, 2019GPNXNOTIFICATION PROCESSED BY IB
Sep 24, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 18, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 18, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 4, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 22, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 16, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 16, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2019ALIEASSIGNED TO LIE
Aug 7, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2019RFNPREFUSAL PROCESSED BY IB
Jul 13, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 13, 2019RFRRREFUSAL PROCESSED BY MPU
Jun 28, 2019MAFRAPPLICATION FILING RECEIPT MAILED
Jun 26, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 25, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2019DOCKASSIGNED TO EXAMINER
Jun 24, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 14, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 6, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance